Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
L01BC06
|
| gptkbp:CASNumber |
113-15-5
|
| gptkbp:category |
gptkb:antineoplastic_agent
gptkb:pyrimidine_analog |
| gptkbp:chemicalFormula |
C6H9NO4
|
| gptkbp:combines |
gptkb:tegafur
gptkb:gimeracil |
| gptkbp:component |
S-1 (oral anticancer drug)
|
| gptkbp:function |
inhibits phosphorylation of 5-fluorouracil in the gastrointestinal tract
|
| gptkbp:purpose |
reduces gastrointestinal toxicity of 5-fluorouracil
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
oteracil potassium
potassium oxonate |
| gptkbp:bfsParent |
gptkb:tegafur
gptkb:Teysuno gptkb:S-1 |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
oteracil
|